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Abstract
Polyadenylation of Rous sarcoma virus (RSV) RNA is inefficient, as approximately 15% of RSV RNAs represent read-through transcripts that
use a downstream cellular polyadenylation site (poly(A) site). Read-through transcription has implications for the virus and the host since it is
associated with oncogene capture and tumor induction. To explore the basis of inefficient RSV RNA 3′-end formation, we characterized RSV
polyadenylation in vitro using HeLa cell nuclear extracts and HEK293 whole cell extracts. RSV polyadenylation substrates composed of the
natural 3′ end of viral RNA and various lengths of upstream sequence showed little or no polyadenylation, indicating that the RSV poly(A) site is
suboptimal. Efficiently used poly(A) sites often have identifiable upstream and downstream elements (USEs and DSEs) in close proximity to the
conserved AAUAAA signal. The sequences upstream and downstream of the RSV poly(A) site deviate from those found in efficiently used poly
(A) sites, which may explain inefficient RSV polyadenylation. To assess the quality of the RSV USEs and DSEs, the well-characterized SV40 late
USEs and/or DSEs were substituted for the RSV elements and vice versa, which showed that the USEs and DSEs from RSV are suboptimal but
functional. CstF interacted poorly with the RSV polyadenylation substrate, and the inactivity of the RSV poly(A) site was at least in part due to
poor CstF binding since tethering CstF to the RSV substrate activated polyadenylation. Our data are consistent with poor polyadenylation factor
binding sites in both the USE and DSE as the basis for inefficient use of the RSV poly(A) site and point to the importance of additional elements
within RSV RNA in promoting 3′ end formation.
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RNA transcripts generated by retroviral proviruses are
produced by the host RNA polymerase II and are subject to
eukaryotic post-transcriptional modifications including 5′ end
capping, RNA splicing, and 3′ end processing by polyadenyla-
tion. In the case of Rous sarcoma virus (RSV), a simple avian
virus, the primary transcript serves as a substrate for RNA
splicing to produce the env and src mRNAs, but in contrast to
most cellular mRNAs, the majority of the RNA remains com-
pletely unspliced and is exported to the cytoplasm to serve as the
gag/pol mRNA and for incorporation as genomes into progeny
virions (Goff, 2007). A number of mechanisms have been
described to account for the accumulation and nuclear export
of the large pool of unspliced retroviral RNA (reviewed in
Cochrane et al., 2006; McNally, 2008). In addition to RNA⁎ Corresponding author. Fax: +1 414 456 6535.
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doi:10.1016/j.virol.2008.01.012splicing control, several interesting observations concerning the
control of RSV polyadenylation have been made. Polyadenyla-
tion in RSV is relatively inefficient in that approximately 15% of
viral mRNA represents read-through transcripts that are poly-
adenylated at downstream cellular sites (Herman and Coffin,
1986). Production of read-through transcripts is important for
viral acquisition of cellular oncogenes like the erbB and fps on-
cogenes captured by avian leucosis/sarcoma viruses (Goff, 2007;
Huang et al., 1986; Raines et al., 1988). While read-through
transcription does not appear to significantly impact viral repli-
cation (Herman and Coffin, 1986; Swain and Coffin, 1989), it can
have severe consequences for the host through the activation of
downstream oncogenes like myb and erbB (Fung et al., 1983;
Kanter et al., 1988), but why the RSV polyadenylation site is
inefficiently utilized is not known.
3′-end processing is a two-step reaction whereby the primary
transcript initially undergoes endonucleolytic cleavage, which
is followed by the addition of the poly(A) tail to the 5′ cleavage
product. At a minimum, polyadenylation requires cis elements
Fig. 1. Polyadenylation substrates used in vitro. A. RSV substrates (to scale).
The proviral 3′ long terminal repeat (LTR) is shown at the top and the structure
of the four RSV substrates is depicted below. The cleavage/poly(A) site (arrow)
is located at the end of the R region. Viral substrates included the entire region
downstream of the RSV poly(A) site (narrow box) and variable lengths of
upstream sequence (wide box). Lengths of specific segments are indicated and
the size of transcribed substrate is indicated at the right. Thin lines indicate short
segments of vector-derived sequence. The positive control SV40 late poly
(A) substrate is shown as shaded boxes with the SVLmut AAGAAA sequence
below. B. Chimeric substrates. Labels and shading are as in A. Dashed vertical
lines delineate the USE region, core poly(A) signal, and DSE regions. The
names of the substrates indicate the source of the three regions. The poly-
adenylation activities relative to SVL are summarized on the right: +, less than
full activity; ++, full activity; and +++, greater than full activity.
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occurs, and include the highly conserved AAUAAA hexanu-
cleotide and a U- or GU-rich downstream element (DSE) (re-
viewed in Zhao et al., 1999). These elements are recognized by
various proteins that identify the polyadenylation site and carry
out the process of cleavage and polyadenylation. The hexamer
is recognized by the cleavage and polyadenylation specificity
factor (CPSF), whose binding is stabilized through an inter-
action with the cleavage stimulation factor (CstF), which rec-
ognizes the U- or GU-rich DSE associated with many poly(A)
sites (MacDonald et al., 1994; Murthy and Manley, 1995; Perez
Canadillas and Varani, 2003). In addition to these core elements
and binding factors, poly(A) site use can be influenced by
additional upstream (USE) and downstream elements. While
auxiliary USEs and DSEs are important for constitutive and
regulated polyadenylation of viral and cellular genes (Arhin
et al., 2002; Bagga et al., 1995; Carswell and Alwine, 1989;
Danckwardt et al., 2007; Lutz and Alwine, 1994; Natalizio
et al., 2002; Schek et al., 1992), few have been characterized
and the factors that bind them remain largely unknown. In
addition to previously described U-rich elements, a number of
cis elements common to strong polyadenylation sites were
recently identified with bioinformatics (Hu et al., 2005). These
observations point to the importance of multiple elements to
ensure proper 3′-end formation of mRNA.
Polyadenylation of genome-length retroviral RNA is also
problematic in that splicing and polyadenylation are coupled
processes (Maniatis and Reed, 2002), prompting the question of
how unspliced RNA is efficiently polyadenylated. RSV 3′-end
formation is novel in that elements that are quite distant from the
RSV poly(A) site are important for 3′ end formation. These
elements include the env 3′ splice site (ss) region and the nega-
tive regulator of splicing (NRS) element, which are ∼4200 and
∼8500 nt away from the poly(A) site, respectively (Fogel et al.,
2002; Miller and Stoltzfus, 1992; O'Sullivan et al., 2002). To
further understand why the RSV poly(A) site is poorly utilized,
we characterized its activity using an in vitro system. Exami-
nation of the regions surrounding the RSV poly(A) site indicates
that the RSV sequences deviate from those found in efficiently
used poly(A) sites, which may explain inefficient viral poly-
adenylation and the requirement for the far-upstream elements.
Our data indicate that theRSVpoly(A) site is inherently inefficient
due to poor USEs and DSEs and, at least in part, to inefficient
CstF binding. Establishing efficient CstF binding through a
tethering approach was sufficient to activate the RSV polyadeny-
lation site in vitro. We speculate that the far-upstream elements
contribute to a novel mechanism for efficient RSV poly(A) site
function to overcome the suboptimal USEs and DSEs.
Results
The RSV poly(A) site is poorly used in vitro
While it is known that RSV mRNA is not efficiently poly-
adenylated in infected cells (Herman and Coffin, 1986) and the
RSV poly(A) site is very poorly used in vitro (Maciolek and
McNally, 2007; Wilusz and Beemon, 2006), the basis for thishas not previously been determined. Because the poly(A)
machinery is highly conserved in vertebrates (Zhao et al., 1999),
HeLa cell nuclear extracts were thus used to examine RSV poly
(A) site in vitro. A similar in vitro strategy was used recently to
examine how the NRS element boosts RSV polyadenylation
(Maciolek and McNally, 2007; Wilusz and Beemon, 2006).
Typically, cis elements important for polyadenylation are found
within 100 nt upstream or downstream of the poly(A) site (Chen
et al., 1995; Hu et al., 2005). It is conceivable that RSV harbors
potentially important distal auxiliary upstream elements that are
outside of this 100 nt limit, and such elements would have been
excluded in the previous studies where only ∼116 and ∼129
nts were included upstream of the poly(A) site. Therefore, RSV
substrates were constructed to contain the entire region down-
stream of the cleavage/polyadenylation site (80 nt) and, to test
for distal upstream elements, 129 nt, 168 nt, or 647 nt of up-
stream sequence was included (Fig. 1A). Substrates were uni-
formly radiolabeled by in vitro transcription and incubated in
HeLa nuclear extract for the indicated times and resolved on
polyacrylamide gels (Fig. 2). Polyadenylation appears as a
slower migrating smear of labeled substrate. The SV40 late
polyadenylation substrate (SVL) was used as a positive control
Fig. 2. RSV substrates are not polyadenylated in vitro. SVL, SVLmut, and the
indicated RSV substrates (shown in Fig. 1A) were uniformly 32P-labeled and
used in a polyadenylation assay in HeLa nuclear extract for the indicated times
(minutes). RNA was processed from the samples and subjected to electrophor-
esis on a 6%–8 M urea polyacrylamide gel, and images were obtained with a
phosphorimager. M, 32P-end-labeled pBR322/MspI markers, sizes are indicated
at the left. Polyadenylation appears as a slower migrating smear for SVL.
Results are representative of at least three independent experiments. Quantita-
tion of polyadenylation at 60 min: SVL, 37%; SVLmut and RSV substrates were
not above background.
470 N.L. Maciolek, M.T. McNally / Virology 374 (2008) 468–476and showed ∼37% polyadenylation after 60 min, and the in-
crease in the size of the labeled substrate was due to polyadenyl-
ation since a version of SVL with the conserved hexanucleotide
mutated from AAUAAA to AAGAAA showed no detectable
polyadenylation (Fig. 2, lanes 2 to 5 and 6 to 9). As observed
previously (Maciolek and McNally, 2007), little or no
polyadenylation was observed with the RSV substrate harbor-
ing 129 nt of upstream sequence (lanes 14–17), and none of the
substrates containing additional upstream sequence were active
(lanes 18–25), indicating that the viral poly(A) site is sub-
optimal and/or the surrounding sequence lacks cis elements
competent to support efficient polyadenylation. A shorter sub-
strate harboring only 75 nts upstream of the poly(A) site was
also inactive, indicating that no negative elements are present
between 75 and 129 nt upstream (lanes 10–13).
Examination of the sequence surrounding the RSV poly(A)
signal indicated that the RSV USEs and DSEs deviate from
those associated with the efficiently used sites such as the SV40
poly(A) site, which may explain why the RSV substrates were
not polyadenylated in vitro. Compared to efficiently used sites,
the RSV downstream region is less U-rich and lacks any sig-
nificant U blocks characteristic of CstF binding sites (MacDo-
nald et al., 1994), which led to the hypothesis that inefficient
RSV polyadenylation is due to suboptimal DSEs that may not
be recognized by CstF. The RSV upstream region also lacks
sequences that are characteristic of the strong sites, exemplified
by the USE of SV40. The SV40 USE has two U-rich regions
that are important for polyadenylation (Schek et al., 1992), one
of which binds U1A (Lutz and Alwine, 1994). The U-rich
regions could also be binding sites for Fip1 (Kaufmann et al.,
2004), and a UGUAA sequence likely binds CF Im (Venkatara-
man et al., 2005). Each of these proteins can promote poly-
adenylation. The RSV upstream region is generally less U-richand has no sequences resembling these elements except for a
potential CF Im site (UGUAU), suggesting that the RSV USEs
are also suboptimal.
The RSV USE and DSE are suboptimal
To experimentally assess the quality of the RSV USEs and
DSEs, the well-characterized SVL USEs and/or DSEs were
substituted for the RSV elements and vice versa (Fig. 1B), and
chimeric substrates were used in polyadenylation assays. The S-
R-S chimera (S refers to SVL, R to RSV), composed of the RSV
core poly(A) signal flanked by the SVLUSEs and DSEs (from 14
nt upstream of the AAUAAA to 7 nt downstream of the cleavage/
poly(A) site), was polyadenylated as well as SVL (21% vs. 24%,
Fig. 3, lanes 2 to 5 and 18 to 21, quantitated in Fig. 3B). This
indicates that the core RSV poly(A) signal and cleavage site are
competent and can be activated when supplied with strong USEs
and DSEs, and suggests that suboptimal USEs and/or DSEs
explain poor RSV polyadenylation in vitro. To assess the quality
of the RSV USEs, a chimeric substrate composed of the RSV
USEs appended to SVL core poly(A) signal and downstream
region (R-SS) was tested and showed a slightly lower level of
polyadenylation than SVL (21% vs. 16%, lanes 26 to 29), which
suggests that the RSVUSEs are suboptimal. Further evidence that
the RSV USEs are suboptimal but functional was seen by the
efficient polyadenylation of the RR-S substrate (15%, lanes 10 to
13) inwhich the DSE of SV40was substituted for the same region
in the RSV substrate. A chimera in which the USEs of SV40were
appended to the RSV poly(A) site and DSEs, S-RR, was poly-
adenylated at least as well as the SVL control (34%vs. 20%, lanes
14 to 17), demonstrating that the RSV USEs are not as strong as
those of SV40. Taken together, the data indicate that the RSV
USEs are functional but suboptimal, in agreement with the pre-
diction from the sequence comparison.
Comparison of the downstream region in RSV to that of SVL
suggested that the RSV DSEs are also suboptimal. Consistent
with this, polyadenylation was activated when the RSV
downstream region was substituted with the SV40 DSE (RR-
S, 15% vs. 4% for RSV; Fig. 3, lanes 10 to 13 and 6 to 9). This
result supports not only the assertion that the DSEs are sub-
optimal but is also consistent with the conclusion from above
that the USEs are suboptimal but functional. However, a sub-
strate in which the RSV DSEs replaced the SV40 DSEs (SS-R)
was also efficiently polyadenylated (27%; lanes 22 to 25). This
indicates that the RSV DSEs are also suboptimal but functional
in the SVL context.
Collectively, these results indicate that the core RSV poly(A)
signal is competent for polyadenylation but is not used in vitro due
to a combination of suboptimal USEs and DSEs. Either element
was sufficient to support polyadenylation when complemented
with elements from the strong SV40 polyadenylation substrate,
but nonetheless they do not support RSV polyadenylation.
The RSV polyadenylation substrate binds CstF poorly
Because most DSEs contain a U/GU-rich binding site for
CstF within 30 nt of the cleavage site (MacDonald et al., 1994),
Fig. 4. CstF binds RSV RNA inefficiently. The indicated substrates were
uniformly 32P-labeled, incubated 20 min in HeLa cell nuclear extract, and
subjected to UV cross-linking for 10 min with 254 nm light. Cross-linked
samples were digested with RNase A and analyzed directly by 10% SDS-PAGE
(lanes 1–10) or immunoprecipitated with a CstF monoclonal antibody followed
by 10% SDS-PAGE (lanes 11–19). Images were obtained with a phosphor-
imager. The migration of markers (kDa) is indicated at the left and position of
CstF64 is indicated at the right (a dot).
Fig. 3. The SVL USEs or DSEs stimulate RSV polyadenylation. SVL, RSV, and chimeric substrates (depicted in Fig. 1B and shown schematically above the names)
were uniformly labeled with 32P and subjected to polyadenylation assays using HeLa cell nuclear extract for the indicated times (in minutes). A. Purified RNAwas
subjected to electrophoresis on a 6%–8 M urea polyacrylamide gel and imaged with a phosphorimager. M, 32P-end-labeled pBR322/MspI markers with sizes indicated
at the left. Polyadenylation appears as a slower migrating smear as indicated at the right. Results are representative of at least three independent experiments.
B. Quantitation of percent polyadenylation at the 30 min time point where substrate degradation was least pronounced.
471N.L. Maciolek, M.T. McNally / Virology 374 (2008) 468–476one explanation for poor RSV polyadenylation in vitro was the
suboptimal nature of the RSV DSEs and poor CstF binding.
This was addressed in UV cross-linking and immunoprecipita-
tion experiments wherein radiolabeled substrates were incu-
bated in HeLa nuclear extract and irradiated with 254 nm light
to crosslink interacting proteins. Cross-linked reactions were
analyzed by SDS-PAGE directly or subjected to immunopre-
cipitation using CstF64 monoclonal antibody 3A7 prior to SDS-
PAGE. CstF64 is the RNA-binding subunit of the CstF hetero-
trimeric polyadenylation factor (Takagaki et al., 1990). SVL and
SVLmut served as positive and negative controls. Of the many
proteins detected in total reactions with SVL, but not SVLmut,
was a band at ∼64 kDa consistent with CstF64, and cross-
linked CstF64 was specifically detected after immunoprecipita-
tion (Fig. 4, lanes 1 and 11 vs. lanes 2 and 12). CstF64 cross-
linking to the RSV substrate was quite low (lanes 3 and 13) but
above background (not visible at this exposure). Chimeric sub-
strates were also examined to assess the effect that substitution
of alternate USEs and DSEs had on CstF binding. CstF64 cross-
linking was detected in total and immunoprecipitated samples
with the chimeras harboring the DSEs from SVL (lanes 4 and
14, 6 and 16, and 8 and 18) but not those with RSV DSEs (lanes
5 and 15, and 7 and 17). These results indicate that CstF binds
472 N.L. Maciolek, M.T. McNally / Virology 374 (2008) 468–476the SVL DSEs regardless of context and suggest that poor CstF
binding may be the predominant deficiency of the RSV DSEs.
Improved CstF binding stimulates RSV polyadenylation
Because the above data indicated that CstF binds poorly to the
RSV DSE, which could underlie inefficient RSV polyadenyla-
tion, we asked if artificial CstF binding could activate RSV
polyadenylation. A tethering assay was employed where two
MS2 bacteriophage coat protein-binding sites were substituted
for the DSEs in SVL (as a positive control), RSV, and the
chimera in which the RSV upstream region was replaced with
SVL USE (S-R-MS2, Fig. 5A). Radiolabeled substrates were
incubated in whole cell extracts frommock-transfected HEK293
cells or cells transfected with expression plasmids forMS2 alone
or anMS2–GFP fusion (negative controls), or MS2 fusions with
full-length CstF64 or a version of CstF64 lacking the RNA-
binding domain (Fig. 5B). The rationale for the latter construct
was that removal of the RNA-binding domain might preventFig. 5. Tethered CstF64 activates polyadenylation of RSV RNA. A. Schematic of teth
larger boxes, downstream regions are narrow boxes, and the MS2 coat protein-bind
Shaded regions are derived from SVL, open boxes from RSV, and transcribed substra
MS2 protein is shown as a white oval and the GFP portion of MS2–GFP is in grey. Tw
region and a second that lacks the N-terminal RNA-binding domain (−RBD, deletion
in the boxes. C. Results of a polyadenylation assay. HEK293 cells were transfected
extracts were made. SVL, RSV, and the MS2 substrates depicted in (A) were 32P-lab
each lane). RNAwas isolated and samples were analyzed on a 6%–8 M urea polyacr
appears as a slower migrating smear as indicated at the right. Results are representa
markers with sizes indicated at the left.titration of the fusion protein by endogenous RNA present in
the cellular extract, which could diminish the activity of the
MS2–CstF64 fusion. The expectation was that binding of the
MS2–CstF64 fusion (after association with the endogenous
CstF50 and CstF77 subunits) to the above substrates would
stimulate polyadenylation.
The wild-type SVL substrate was polyadenylated in all
extracts (∼16% on average, Table 1) except that which
contained MS2 alone (Fig. 5C, lanes 2–7), indicating that the
whole cell extracts are polyadenylation competent. It is unclear
why the MS2 coat protein alone elicits the inhibition, but this
was reproducible but not observed with the MS2–GFP control
(lane 5). As expected, little or no polyadenylation was observed
for the RSV substrate in any extract (lanes 9–13). The effec-
tiveness of the tethering system was demonstrated with SVL
containing the MS2 recognition sequence directly downstream
of the cleavage/polyadenylation site. A low level of poly-
adenylation (∼1%) was observed with mock and control
transfected cell extracts (lanes 15 to 17 and Table 1), but theering substrates. Regions upstream of the cleavage/poly(A) site are indicated by
ing sites are shown as stem loops. Sizes of the various segments are indicated.
te sizes are indicated at the right. B. Schematic of MS2 coat protein fusions. The
o MS2–CstF64 fusions were used, one containing the full-length CstF64 coding
indicated by a line). Lengths of the protein segments in amino acids are indicated
with constructs expressing the fusion proteins described in (B) and whole cell
eled and incubated for 1 h in the various HEK293 cell extracts (indicated above
ylamide gel, and images were obtained with a phosphorimager. Polyadenylation
tive of at least two independent experiments. M, 32P-end-labeled pBR322/MspI
Table 1
Percent polyadenylation of MS2-site containing substrates in vitro in the
presence of various MS2 fusion proteins
None MS2 MS2–
GFP
MS2–
CstF64
MS2–
ΔRBD
Substrate % SDa % SD % SD % SD % SD
SVL 20.2 6.3 3.2 0.6 12.4 2.8 14.6 2.3 19.1 4.6
RSV 0.1 0.1 0.1 0.1 nd b nd 0.1 0.0 nd nd
SVL-MS2 1.6 1.5 0.6 0.2 1.6 0.7 4.0 0.2 11.7 0.8
RSV-MS2 0.6 0.1 nd nd 0.5 0.1 2.2 0.3 4.6 0.4
S-R-MS2 2.3 0.1 0.4 0.3 2.1 0.2 5.1 0.5 11.0 1.3
a SD, standard deviation resulting from two or more independent experiments.
b nd, not detectable.
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was observed in the MS2–CstF64 extracts (4% with MS2–
CstF64 and 12% MS2–CstF64(−RBD); lanes 18 and 19).
Importantly, the RSV-MS2 substrate was also polyadenylated
significantly above controls (lanes 21 to 23) when incubated in
extracts containing the MS2–CstF64 fusions (2% with MS2–
CstF64, 5% with MS2–CstF64(−RBD); lanes 24 and 25).
These data indicate that tethered CstF64 can activate RSV
polyadenylation and suggest that poor CstF binding is one
explanation for inefficient use of the RSV poly(A) site in vitro.
The chimeric SVL-RSV substrate containing downstream
MS2 sites was also polyadenylated more efficiently in extracts
from MS2–CstF64 fusion-transfected cells (5% with MS2–CstF
and 11% with MS2–CstF(−RBD), Fig. 5C, lanes 30 and 31)
compared control extracts (lanes 27–29). This substrate was
polyadenylated more efficiently than RSV-MS2, indicating that
the USEs from SVL contribute to more efficient polyadenylation.
Discussion
Polyadenylation is inherently inefficient in many retro-
viruses, including RSV. The data presented here indicate that
RSV substrates are poorly polyadenylated in vitro due to sub-
optimal USEs and DSEs. The core poly(A) signal is functional
since it was activated when placed in the context of USEs and
DSEs from the efficiently used SV40 polyadenylation site.
While weak, the RSV USEs and DSEs could function in certain
contexts as demonstrated by increased polyadenylation when
substituted individually into the SV40 context. However, in the
RSV context the combination of USEs and DSEs did not
support polyadenylation and a novel tethering assay supported
suboptimal CstF binding as an explanation, in part or in whole,
for inefficient RSV polyadenylation in vitro.
The RSV poly(A) signal lacks flanking U-rich CstF binding
sites that are characteristic of many DSEs (Hu et al., 2005;
MacDonald et al., 1994; Tian et al., 2005). The observations that
CstF64 did not efficiently crosslink to the RSV substrate and that
artificial tethering of CstF64 activated polyadenylation support
the hypothesis that poor CstF binding contributes to the inherent
weakness of the RSV poly(A) signal. In contrast, CstF binding to
the HIV-1 poly(A) site, which is also inherently weak but benefits
from an upstream poly(A) enhancer, is readily detectable
(Gilmartin et al., 1995). Interestingly, CstF binding may not bea definitive determinant of poly(A) site use since polyadenylation
efficiency did not correlate with CstF64 binding in the RSV
chimeric substrates; the RSV chimera containing the upstream
elements from SVL (S-RR) was efficiently polyadenylated even
though CstF binding, as assessed by UV cross-linking, was not
markedly improved. One possibility is that in the RSV context,
binding of a factor(s) to the SVL USEs stimulates polyadenyla-
tion independent of CstF. However, it cannot be excluded that
CstF binds in a manner that is refractory to CstF64 cross-linking
or is recruited independent of RNA-binding. These data support a
general model for poly(A) site recognition in which many factors
function to identify the poly(A) site through binding to USEs and
DSEs or other auxiliary elements, and certain factors are able to
compensate for the suboptimal binding of others (Takagaki et al.,
1996; Venkataraman et al., 2005).
The region upstream of the RSV poly(A) site also lacks
significant U-rich regions characteristic of USEs associated with
strong polyadenylation signals. Factors that are known to bind to
USEs in other systems include hFip1, U1A protein, and CF Im.
Fip1 is a poly(U)-binding subunit of CPSF that stimulates polyA
polymerase and has been shown to bind the USEs associated
with the papillomavirus type 16 early poly(A) signal and the
adenovirus L3 poly(A) signal (Kaufmann et al., 2004; Zhao
et al., 2005). hFip would not be expected to bind the RSV USE
since it lacks U-rich elements. U1A, a protein component of U1
snRNP, is reported to act as both an enhancer and repressor of
polyadenylation (Boelens et al., 1993; Gunderson et al., 1994,
1998; Lutz et al., 1996; Wassarman and Steitz, 1993). It has also
been suggested that a complex of U1A and other non-snRNP
proteins can play a role in splicing and polyadenylation (Lutz
et al., 1998; O'Connor et al., 1997). U1A is not predicted to bind
the RSV substrate since it lacks the suggested AUUUGUAAC
binding site defined in SV40. Recently, it was shown that CF Im
can be a primary determinant for recognition of noncanonical
poly(A) sites but that sequence-specific binding of CF Im to
USEs can also promote recognition of canonical AAUAAA
polyadenylation sites (Venkataraman et al., 2005). While RSV
lacks extensive U-rich regions, it does have a consensus CF Im
binding site (UGUAA) and CF Im binds the RSV substrate (data
not shown), which could explain why the RSV USE functions
when supplemented with the strong SVL DSEs.
Two other retroviruses, HIV-1 and equine infectious anemia
virus (EIAV), display suboptimal core polyadenylation signals
that are stimulated by sequences within the upstream U3 region
(Gilmartin et al., 1995; Graveley and Gilmartin, 1996;
Valsamakis et al., 1992). These USEs increase the stability of
CPSF binding to promote cleavage and poly(A) addition and, in
addition to secondary structure and the suppressive activity of
U1 snRNP when bound to the major splice donor (Ashe et al.,
2000; Das et al., 1999), explain why poly(A) addition occurs
selectively at the 3′ end of the message. RSV does not appear to
harbor such a poly(A) enhancing USE within U3, since sub-
strates including sequences well upstream of U3 failed to be
polyadenylated. As with RSV, the poly(A) site of Moloney
murine leukemia virus (MoMLV) is also inherently weak but
differs in having an identifiable GU-rich DSE (Furger et al.,
2001), but why this site is poorly used remains to be clarified.
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signal in vitro due to suboptimal USEs and DSEs and, at least
in part, to poor CstF binding. How, then, is the RSV signal
utilized in vivo? In contrast to a role for U3 sequences as
observed in HIV-1 and EIAV, an early report indicated that two
far-upstream elements were both required for normal RSV
polyadenylation. One element comprised the env 3′ ss region,
and the other located within the gag gene mapped to the NRS
(Fogel et al., 2002; Miller and Stoltzfus, 1992; O'Sullivan et al.,
2002). The NRS, a splicing suppressor that binds U1 snRNP via
SR protein splicing factors, is proposed to act as a pseudo-5′ ss
that forms an arrested splicing complex with the downstream
viral 3′ splice sites, thus preventing their interaction with the
authentic 5′ ss (Cook and McNally, 1999; Giles and Beemon,
2005; Hibbert et al., 1999; McNally and McNally, 1999;
reviewed in McNally, 2008). The SR protein and U1 snRNP
binding sites within the NRS and the env 3′ ss region are each
required for optimal RSV polyadenylation (Fogel et al., 2002;
O'Sullivan et al., 2002), and while NRS splicing control is fairly
well understood, details on how the NRS and the env 3′ ss
region conspire to promote RSV polyadenylation only recently
came to light.
Although it was recently shown that the NRS alone stimu-
lates polyadenylation of RSV substrates in vitro through SR
protein-binding to the upstream portion of the NRS (Maciolek
and McNally, 2007; Wilusz and Beemon, 2006), SR protein-
binding sites promoted polyadenylation in proviral constructs
only when positioned artificially close to the poly(A) site or
when the assembly of the NRS–3′ss complex was maintained
(Maciolek and McNally, 2007). The evidence supports a model
whereby the NRS–env 3′ ss interaction is needed to bridge the
∼8500 nt between the NRS and the poly(A) site to position the
SR proteins closer to the viral poly(A) site. It is also possible
that other NRS complex components promote polyadenylation,
perhaps through conventional coupling interactions, and that
these interactions collectively ensure that the majority of the
RSV transcripts are correctly polyadenylated at the otherwise
weak poly(A) site. Thus, unlike other retroviruses that use
nearby enhancer elements in U3 to promote polyadenylation at
suboptimal poly(A) sites, RSV has evolved a novel mechanism
that involves the interaction of a splicing regulatory element
(the NRS) and a viral 3′ ss to reposition SR proteins for stimu-
lation of the inherently weak poly(A) site.
Materials and methods
Plasmid constructs
p3Z-RSVPvuI–PstI, which was used to generate substrate
129pA, and p3Z-SVL were described previously (Maciolek and
McNally, 2007). To generate other in vitro polyadenylation sub-
strates, varying lengths of RSV DNA obtained from pBSKS+
RSVSalI–SacII (which contains a 1174 bp SalI–SacII fragment
from pAPrC that surrounds the 5′ LTR and was described
previously (Maciolek and McNally, 2007)) (Prague C strain,
numbering of Schwartz et al. (1983)) were inserted into pGEM-
3Z (Promega). A 316 bp EcoRI–PstI fragment was insertedinto the same sites of pGEM-3Z to generate p3Z-RSVEcoRI–PstI
(for substrate 166pA). A 403 bp SphI–PstI fragment and a
909 bp KpnI–PstI fragment were inserted into the same sites of
pGEM-3Z to generate p3Z-RSVSphI–PstI (for substrate 269pA)
and p3Z-RSVKpnI–PstI (for substrate 771pA), respectively. p3Z-
SVLmut had the canonical AAUAAA hexanucleotide in p3Z-
SVLmutated toAAGAAAbyoverlap PCR (Ausubel et al., 1998)
and the fragmentwas subsequently cloned into the EcoRI and SalI
sites of pGEM-3Z. All primer sequences are available upon
request. RSV and SVL chimeric substrates were constructed by
overlap PCR and for simplicity, constructs are named in three
parts describing the origin of the USE, core poly(A) signal, and
DSE. pRSV-RSV-SVL is thus composed of the RSV USE and
core poly(A) signal followed by the DSE fromSVL and generates
a substrate with 87 nt of RSV USE, 42 nt upstream and 7 nt
downstream of the RSV cleavage/poly(A) site, followed by 92 nt
of SVL DSE. pSVL-SVL-RSV consists of 111 nt of SVL USE,
core sequences from −33 to +7 relative to the cleavage/poly(A)
site, followed by 243 nt of RSV DSE. pRSV-SVL-SVL contains
87 nt of RSV USE appended to SVL core sequences −33 to +7,
and 105 nt of SVLDSE. pSVL-RSV-SVL contains 111 nt of SVL
USE fused to RSV core sequences −42 to +7 nt, followed by 105
nt of SVL DSE. pSVL-RSV-RSV contains 111 nt of SVL USE
fused to RSV core sequences −42 to +7, followed by 243 nt of
RSV DSE. The chimeric fragments were inserted into EcoRI and
HindIII sites of pGEM-3Z, or into SacI and HindIII for pRSV-
RSV-SVL and KpnI and HindIII for pRSV-SVL-SVL, then
verified by DNA sequencing. Plasmids harboring tethering sub-
strates contained two MS2 coat protein-binding sites and were
constructed by overlap PCR. The SVL tethering substrate, p3Z-
SVL-MS2, has SVL sequence from−137 to the cleavage/poly(A)
site where a 77 bp fragment harboring twoMS2 binding sites was
directly inserted (cloned in the EcoRI and HindIII sites of pGEM-
3Z). pRSV-MS2 and pSVL-RSV-MS2 were constructed by
replacing the RSV DSE in p3Z-RSVPvuI–PstI and pSVL-RSV-
RSV with a 77 bp MS2 site XmaI–HindIII fragment from p3Z-
MS-MS2 (McNally et al., 2006). pRSV-MS2 has RSV sequences
−128 to +29, followed by the 77 nt fragment harboring twoMS2
binding sites. pSVL-RSV-MS2 has 158 nt of SVL USE fused to
RSV sequences −42 to +29, followed by the MS2 binding sites.
Constructs for expressing MS2–CstF fusion proteins were made
by overlap PCR using pcDNA-MS2 (McNally et al., 2006) and
pZ64-18hCstF64 templates (kindly provided by C.C. MacDo-
nald, Texas Tech University, TX) (Takagaki et al., 1992).
p3XFLAG-MS2–CstF has the 418 bpMS2 coat protein sequence
obtained from pcDNA-MS2 upstream of the 1734 bp CstF read-
ing frame cloned such that the expressed protein includes a 3X
FLAG tag. p3XFLAG-MS2–CstF(−RBD) has the MS2 coat
protein sequence fused to the 3′ 1446 bp of CstF, downstream of
the RNA-binding domain. The fragments were inserted into
p3XFLAG-CMV-7.1 (Sigma) using XbaI sites that had been
appended to the overlap PCR fragments. For p3XFLAG-MS2,
the MS2 coat protein sequence was removed from pcDNA-MS2
with XbaI and XhoI, and the DNAwas then shuttled into the XbaI
and SmaI sites p3XFLAG-CMV-7.1. p3XFLAG-MS2–GFP was
made by excising a 784 bp XhoI–NotI fragment from pEGFP-N1
(Clonetech), blunting theNotI site, and inserting theDNA into the
475N.L. Maciolek, M.T. McNally / Virology 374 (2008) 468–476XhoI and blunted BamHI sites of pcDNA-MS2. The fusion was
then removed using XbaI and AflII-blunt, and the fragment was
shuttled into the XbaI and SmaI sites of p3XFLAG-CMV-7.1.
Polyadenylation assays
RSV plasmids were linearized with BstEII and p3Z-SVL was
linearized with HindIII. RNAwas transcribed in vitro with T7 or
SP6 polymerase and [32P]-UTP in a capping reaction (Melton
et al., 1984) and purified on a 6%–8 M urea polyacrylamide
gel. Polyadenylation reactions were performed using 50,000 cpm
labeled substrate (∼2 fmol depending on substrate specific
activity), 2.6% poly-vinyl alcohol, 1 mM ATP, 20 μM creatine
phosphate, 1mMMgCl2, and 50%HeLa nuclear extract (Dignam
et al., 1983) or, for tethering experiments, HEK293 whole cell
lysates (Kataoka and Dreyfuss, 2004). Reactions were incubated
at 30 °C for times specified in the figure legends, proteinase K
treated, phenol extracted, ethanol precipitated, and resolved on a
6%–8 M urea polyacrylamide gel. Images were obtained using a
Storm 820 PhosphorImager (Amersham Biosciences) and/or
autoradiography. Polyadenylation was quantitated using Image-
Quant software (Amersham Biosciences) and, to control for
degradation of substrates, efficiency was calculated as the phos-
phorimager units in the polyadenylated product divided by the
units in the substrate at time zero.
UV cross-linking and immunoprecipitation
Labeled RNA substrates were prepared as described above
and used in UV cross-linking reactions that contained 1 mM
ATP, 20 μM creatine phosphate, 0.2 μg/μl tRNA, 200,000 cpm
labeled substrate, and 25% HeLa nuclear extract. The reactions
were incubated for 20 min at 30 °C and then irradiated for
10 min at 4 °C with 254 nm UV light at a distance of 5 cm.
Reactions were RNase A digested and proteins were analyzed
by 10% SDS-polyacrylamide gel electrophoresis (PAGE). For
immunoprecipitation, reactions were incubated 1 h at 4°C with
protein A-Sepharose beads that were pre-loaded with 0.5 μg
rabbit-anti-mouse IgG (Bethyl Laboratories) per μl beads and
2.5 μl CstF64 monoclonal antibody 3A7 per μl beads
(generously donated by C.C. MacDonald, Texas Tech Uni-
versity, TX). Beads were then washed with IP buffer (50 mM
Tris pH7.5, 150 mM NaCl, 0.1% Triton X-100) and precipi-
tates were eluted with 2× SDS-PAGE solubilizing buffer with-
out β-mercaptoethanol. Reactions were separated by 10% SDS-
PAGE and images were obtained by Storm 820 PhosphorImager
(Amersham Biosciences) or autoradiography.
Transfection of HEK293 cells and whole cell lysate
preparation
HEK293 cells were grown to 60% confluence in 10 cm dishes
in minimal essential medium supplemented with 10% fetal calf
serum. Cells were mock transfected or transfected with 5 μg
p3XFLAG-MS2, p3XFLAG-MS2–GFP, p3XFLAG-MS2–CstF,
or p3XFLAG-MS2–CstF(−RBD) using calcium phosphate
method (Amersham Biosciences). Cells were harvested andwhole cell extracts were prepared 48 h post-transfection as pre-
viously described (Kataoka and Dreyfuss, 2004). To verify
protein expression byWestern blot, cell lysates were subjected to
10% SDS-PAGE and transferred to a nitrocellulose membrane by
electrotransfer. Immunoblotting was performed as described
(Ausubel et al., 1998) with an anti-FLAGM2monoclonal prima-
ry antibody (Sigma) and goat anti-mouse IgMμ HRP-conjugated
secondary antibody (Upstate). Blots were developed using Super-
signal West Pico Chemiluminescent Substrate (Pierce).
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